https://www.rethinkmeds.info/article/sources-of-innovation-in-gene-therapies-approaches-to-achieving-affordable-prices 2023-01-21 https://www.rethinkmeds.info/article/invited-commentary-on-interventional-pharmacoepidemiology-origins-current-status-and-future-possi 2024-10-10 https://www.rethinkmeds.info/article/dangerous-deception-hiding-the-evidence-of-adverse-drug-effects 2007-04-26 https://www.rethinkmeds.info/article/progress-and-hurdles-for-follow-on-biologics 2015-05-06 https://www.rethinkmeds.info/article/the-elderly-and-drug-policy-coming-of-age 1990-09-01 https://www.rethinkmeds.info/article/bench-to-behavior-translating-comparative-effectiveness-research-into-improved-clinical-practice 2010-10-30 https://www.rethinkmeds.info/article/the-high-cost-of-prescription-drugs-in-the-united-states-origins-and-prospects-for-reform 2016-08-23 https://www.rethinkmeds.info/article/two-centuries-of-assessing-drug-risks 2012-01-30 https://www.rethinkmeds.info/article/teaching-clinicians-about-drugs-50-years-later-whose-job-is-it 2011-03-31 https://www.rethinkmeds.info/article/physician-perspectives-on-pharmaceutical-promotion 2025-09-05 https://www.rethinkmeds.info/article/pharmaceutical-industry-money-can-t-replace-nih-funding 2025-10-22 https://www.rethinkmeds.info/article/evidence-is-our-north-star 2026-05-11 https://www.rethinkmeds.info/article/rethinking-medications-uncovering-the-truth-about-common-drugs 2025-09-08 https://www.rethinkmeds.info/article/the-psychology-of-clinical-decision-making-implications-for-medication-use 2018-02-21 https://www.rethinkmeds.info/article/a-new-way-to-contain-unaffordable-medication-costs 2026-04-30 https://www.rethinkmeds.info/article/a-doctor-s-fix-for-america-s-ailing-medication-market 2025-04-21 https://www.rethinkmeds.info/article/an-overview-of-vaccine-development-approval-and-regulation-with-implications-for-covid-19 2020-11-19 https://www.rethinkmeds.info/article/the-us-presidential-election-s-high-stakes-for-the-future-of-medicine 2024-09-20 https://www.rethinkmeds.info/article/healing-our-de-commissioned-fda 2026-06-16 https://www.rethinkmeds.info/article/the-fda-amendments-act-of-2007-assessing-its-effects-a-decade-later 2018-09-19 https://www.rethinkmeds.info/article/the-trouble-with-do-your-own-research-for-drugs 2025-05-22 https://www.rethinkmeds.info/article/the-rise-and-fall-of-natrecor-for-congestive-heart-failure-implications-for-drug-policy 2006-08-01 https://www.rethinkmeds.info/article/the-price-of-crossing-the-border-for-medications 2017-07-27 https://www.rethinkmeds.info/article/are-your-medicines-safe-and-effective 2025-06-26 https://www.rethinkmeds.info/article/will-trumprx-actually-lower-drug-prices 2025-10-16 https://www.rethinkmeds.info/article/a-critical-appraisal-of-the-state-of-the-prescription-medications-in-the-us 2025-05-28 https://www.rethinkmeds.info/article/part-d-for-defective-the-medicare-drug-benefit-chaos 2006-03-30 https://www.rethinkmeds.info/article/improving-drug-therapy-decisions-through-educational-outreach-a-randomized-controlled-trial-of-aca 1983-06-16 https://www.rethinkmeds.info/article/institutionalizing-misinformation 2026-04-30 https://www.rethinkmeds.info/article/review-powerful-medicines 2004-08-20 https://www.rethinkmeds.info/article/the-fda-breakthrough-drug-designation-four-years-of-experience 2018-04-11 https://www.rethinkmeds.info/article/post-script-rethinking-medications-with-dr-jerry-avorn-md 2025-08-25 https://www.rethinkmeds.info/article/review-rethinking-medications 2025-04-22 https://www.rethinkmeds.info/article/a-path-to-fair-drug-pricing 2025-07-31 https://www.rethinkmeds.info/article/the-us-pays-some-of-the-highest-drug-prices-in-the-world-can-trump-fix-that 2025-05-15 https://www.rethinkmeds.info/article/academic-detailing-can-play-a-key-role-in-assessing-and-implementing-comparative-effectiveness-resea 2013-10-12 https://www.rethinkmeds.info/article/managing-drug-risk-information-what-to-do-with-all-those-new-numbers 2009-11-12 https://www.rethinkmeds.info/article/the-25th-anniversary-of-a-nearly-unknown-health-policy-turning-point 2026-06-16 https://www.rethinkmeds.info/article/the-2-6-billion-pill-methodologic-and-policy-considerations 2015-05-14 https://www.rethinkmeds.info/article/the-future-of-drug-pricing-transparency 2021-01-13 https://www.rethinkmeds.info/article/priced-out-in-conversation-with-dr-jerry-avorn 2025-10-15 https://www.rethinkmeds.info/article/balancing-innovation-access-and-profits-market-exclusivity-for-biologics 2009-11-12 https://www.rethinkmeds.info/article/interview-with-post-scrip 2025-08-25 https://www.rethinkmeds.info/article/review-rethinking-medications-1 2025-01-23 https://www.rethinkmeds.info/article/the-roles-of-academia-rare-diseases-and-repurposing-in-the-development-of-the-most-transformative 2015-02-01 https://www.rethinkmeds.info/article/drug-evaluation-during-the-covid-19-pandemic 2020-04-14 https://www.rethinkmeds.info/article/harvard-doc-takes-on-big-pharma 2025-05-11 https://www.rethinkmeds.info/article/countering-the-drug-marketing-machine 2025-11-13 https://www.rethinkmeds.info/article/provenance 2025-10-23 https://www.rethinkmeds.info/article/trump-s-ongoing-tariff-chaos-will-make-medications-less-affordable-and-harder-to-find 2025-07-02 https://www.rethinkmeds.info/article/tariffs-added-strain-on-the-us-health-care-system 2025-09-18 https://www.rethinkmeds.info/article/up-is-down-pharmaceutical-industry-caution-vs-federal-acceleration-of-covid-19-vaccine-approval 2020-09-15 https://www.rethinkmeds.info/article/the-21st-century-cures-act-will-it-take-us-back-in-time 2015-06-25 https://www.rethinkmeds.info/article/review-rethinking-medications-is-an-important-book-of-our-time 2025-05-28 https://www.rethinkmeds.info/article/paying-for-drug-approvals-who-s-using-whom 2007-04-26 https://www.rethinkmeds.info/article/a-new-approach-to-reducing-suboptimal-drug-use 1983-10-07 https://www.rethinkmeds.info/article/in-defense-of-pharmacoepidemiology-embracing-the-yin-and-yang-of-drug-research 2007-11-29 https://www.rethinkmeds.info/article/new-alzheimer-s-drug-is-a-problem-for-fda-s-pass-fail-approach 2023-06-15 https://www.rethinkmeds.info/article/risk-responsibility-and-generic-drugs 2012-11-01 https://www.rethinkmeds.info/article/a-randomized-trial-of-a-program-to-reduce-the-use-of-psychoactive-drugs-in-nursing-homes 2026-04-30 https://www.rethinkmeds.info/article/corporate-support-cannot-make-up-for-threats-to-the-nih-budget 2025-10-22 https://www.rethinkmeds.info/article/the-truth-about-your-medications-with-harvard-s-dr-jerry-avorn 2025-08-11 https://www.rethinkmeds.info/article/rethinking-medications-from-academic-detailing-to-broken-drug-regulation 2026-01-25 https://www.rethinkmeds.info/article/the-failure-of-solanezumab-how-the-fda-saved-taxpayers-billions 2017-05-04